Study on influence of TRPA1 in gastric cancer based on cellular metabolomics and mechanism
10.3969/j.issn.1001-1978.2021.08.025
- Author:
Rui DENG
1
;
Su-Yun YU
1
;
Yuan-Yuan WU
1
;
Xiao-Man LI
1
;
Wen-Xing CHEN
1
;
Ai-Yun WANG
1
;
Yin LU
1
;
Wen-Xing CHEN
2
;
Ai-Yun WANG
2
;
Yin LU
2
Author Information
1. Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy
2. Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine
- Publication Type:Journal Article
- Keywords:
cancer metastasis;
cardamonin;
gastric cancer;
GC-MS;
meta-bonomics;
TRPAI
- From:
Chinese Pharmacological Bulletin
2021;37(8):1176-1183
- CountryChina
- Language:Chinese
-
Abstract:
Aim To explore the effect of THPA1 in the metasta- sis of gastric cancer and the underlying mechanism. Methods The correlation between TRPA1 and the survival time of gastric cancer patients was analyzed using Kaplan-Meier plotter data base. The expressions of TRPA1 in different cells were detected by Western blot. Docking was used to explore the binding poten tial between cardamonin and TRPA1. Long-term dynamic cell imaging, CCK-8 and Transwell were used to evaluate the effects of HC-030031 and cardamonin on the proliferation and migration of MKN-45 cells. The differential metabolites between normal gastric epithelial cells and gastric cancer cells were studied by GC-MS. Results The expression of TRPA1 in gastric cancer patients was significantly negatively correlated with their surviv al. TRPA1 was overexpressed in gastric cancer cells. And the migration of gastric cancer cells was positively correlated with the expression and activation of TRPA1. Cardamonin had similar pharmacological effects with HC-030031, both of which could reduce the migration of gastric cancer cells. The metabolic path ways of asparagine and myo-inositol were found to be different between gastric cancer cells and normal gastric epithelial cells by cell metabolomics analysis. Conclusions TRPAI may be an indicator for detecting gastric cancer metastasis. Cardamonin in hibits metastasis by binding to TRPAI, meanwhile restrains the activation of TRPAI. Cardamonin may inhibit the function of TRPAI by binding to TRPAI, playing a role in inhibiting gastric cancer metastasis.
